Ranbaxy crosses the billion dollar mark

New Delhi: Ranbaxy Laboratories Ltd has achieved the distinction of crossing the billion-dollar mark by 2004. In February, the global sales of the company touched $1billion on a moving annual total basis.

According to a company statement, "In the year 1993, Ranbaxy enunciated its vision to become a $1-billion company by 2004. The credit for this successful achievement truly belongs to the combined efforts of the over 9,000-strong Ranbaxy family."

It is currently pursuing its goal of becoming a $5-billion company $5-billion company as part of the Garuda Vision. And to achieve this, Ranbaxy is spreading its wings across the globe. The company is selling its products in over 70 countries and has manufacturing operations in seven countries.

While the international markets continue to be the focus area for the company due to high margins, it will not lose sight of the domestic business. It plans to launch over 20 products this year and the main therapeutic areas would be cardiovascular, anti-infective, gastro-intestinal and central nervous system.